Pan-Cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance Via Triggering Cytotoxic T Lymphocytes Dysfunction
Junquan Song(Fudan University), Xiaowen Liu(Westlake University), Runyu Yang(Hebei Agricultural University), Rongyuan Wei(Shanghai Academy of Social Sciences), Pengcheng He(Guangdong General Hospital), Yue Du(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 0
Related Papers
Magnesium Levels in Drinking Water and Coronary Heart Disease Mortality Risk: A Meta-Analysis
|Nutrients|2016|100
Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response
|Nature Communications|2025|84
LncRNA‐CCAT5‐mediated crosstalk between Wnt/β‐Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity
|Cancer Communications|2023|58
Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction
|Molecular Medicine|2022|39
Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
|Frontiers in Immunology|2022|31